Comparison

Read by QxMD vs Evidencio

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Read by QxMD

Access and organize the latest medical research and topic reviews in a personalized digital journal. Stay updated with new scientific findings and easily retrieve full-text PDFs from PubMed and other sources.

Highlights
  • Personalized digital medical journal
  • Access latest medical research
  • Read topic reviews
  • Search PubMed
  • Full-text PDF access
  • Organize article collection
Features
Read full description

'Read by QxMD' provides a single place to keep up with new medical & scientific research, read outstanding topic reviews and search PubMed. This iPhone & iPad app provides a simple interface that drives discovery and seamless access to the medical literature by reformatting it into a personalized digital journal. Praise for Read: 5 stars: "Stellar. The future of medical literature review... This could be the best application to stay up-to-date in medicine since, well, UpToDate." - User Review 4¾ stars: "The Flipboard for medical journals has arrived" and among "...the most innovative medical apps" - iMedicalApps.com On Apple's 'What's Hot' list in >60 countries, as well as Medical Essentials & Apps for Healthcare Professionals. Featured in Apple iBook: "iOS in Healthcare: Revolutionizing Healthcare Productivity"   Features: - Get full text PDFs with one tap - Keep up with the latest new research that will impact your practice - Browse through 1000s of outstanding topic reviews - Search millions of articles from PubMed and our database of outstanding topic reviews - Read your favorite journals or browse article collections. - Access full text through your university/institutional subscription or via open access publishers - Share articles with colleagues over email, Twitter and Facebook - Organize and review your personal collection of articles Why did we build 'Read by QxMD'? Health care professionals need to stay up to date on the latest medical research and topic reviews to provide optimal care. Unfortunately, the process of content discovery is broken with research artificially compartmentalized by publishers and hidden behind countless institutional pay walls. At QxMD, we believe that knowledge translation– the process by which new knowledge is incorporated into clinical practice – is an important and unsolved challenge for our health care system. We hope that ‘Read by QxMD’ will be a part of the solution. Seamless 1-tap access available at thousands of institutions. Sources: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. Founded by medical professionals, QxMD is dedicated to creating high quality point-of-care tools for practicing health care professionals.

About

Evidencio

Features
Read full description

With the Evidencio App you can quickly access and use medical prediction models and calculators from Evidencio.com. Evidencio.com hosts the world's first open and transparent library of online medical prediction models and calculators, created by and for medical professionals and researchers. The Evidencio App allows guest users to navigate and use all public models available from Evidencio.com. Registered users can configure favorite models for quick access. As a registered user you're also able to create your own models on Evidencio.com and subsequently use them as private or privately shared models in the App.

Screenshots

Read by QxMD4 screens
Evidencio4 screens

Verdict

The call

The clearest difference is ads: Evidencio at none against Read by QxMD's shown. Evidencio also leads on iOS requirement (13.0 vs 17.6). On price, update cadence, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

Read by QxMD ships an update monthly, Evidencio every 5 weeks. The most recent releases landed on October 24, 2026 and October 10, 2026 respectively.

Scorecard2 real differences · 8 level
Read by QxMD versus Evidencio: the parameters behind the verdict, then further details
ParameterRead by QxMDEvidencio
PriceFreeFree
Rating4.8 (6K ratings) — better—
Positive reviews89.0% of reviews—
Number of ratings6K — better—
Update frequencyMonthly — betterEvery 5 weeks
AdsYesNo — better
In-app purchasesNoNo
MonetizationFree with in-app purchases—
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS17.613.0 — better
Further details — not scored
Size205 MB15 MB
Age rating17+17+
DeveloperWebMDEvidencio B.V.

Bugs and requests

Read by QxMD

Reported bugs

5 issues
  • Login and authentication problems
  • Inconsistent app performance after updates
  • Inability to access full-text articles
  • Syncing issues between devices
  • Unreliable article refresh functionality

Requested features

6 requests
  • Dark mode option
  • Ability to annotate and highlight PDFs
  • Improved article organization and collections
  • Integration with reference managers (e.g. Zotero, Mendeley)
  • Enhanced search and filtering capabilities
Show 1 more
  • Offline access to saved articles

Evidencio

Not enough reviews yet to summarise bugs or requests.

In-app purchases

None

Read by QxMD

No in-app purchases

None

Evidencio

No in-app purchases

Questions

Is Read by QxMD free?
Read by QxMD is free to download, with no in-app purchases.
Is Evidencio free?
Evidencio is free to download, with no in-app purchases.
Do Read by QxMD or Evidencio have ads?
Read by QxMD shows ads; Evidencio does not.
Which is updated more often, Read by QxMD or Evidencio?
Read by QxMD ships an update monthly, and Evidencio every 5 weeks. Most recently, Read by QxMD was updated on October 24, 2026 and Evidencio on October 10, 2026.

Other comparisons